27707 / Pixabay

ICYMI: SRP-9003 Study Shows Positive Results for Treating LGMD Type 2E

Post author:Jessica Lynn
Post published:June 22, 2020
Post category:Limb-girdle muscular dystrophy with delta-sarcoglyan deficiency Limb-girdle muscular dystrophy- type 2B Limb-girdle muscular dystrophy- type 2C Muscular Dystrophy

In a recent press release, biotechnology company Sarepta Therapeutics announced positive findings from their clinical trial studying SRP-9003 as a treatment for limb-girdle muscular dystrophy (LGMD) type 2E. This…

Get Involved

Ready to get involved with Patient Worthy? Share your authentic story with others. Raise awareness and inspire change!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Get Involved

ICYMI: SRP-9003 Study Shows Positive Results for Treating LGMD Type 2E

Metastatic Breast Cancer: Navigating Grief

Rethinking What It Means to Live With Acromegaly

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

Get Involved

Let’s Work Together!

Keep Up to Date

Learn More